focus -WSS

focus

author：knowledge 2025-08-26 07:45:17 - browse：7774

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Republican states more likely to report Covid vaccine side effects

focus

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Why we need mandatory labeling of GMO products

The world needs the new pandemic treaty

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Should insurance cover cosmetic surgery?

The Bio Revolution is changing business and society

Wikipedia

focus

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

U.S. death rates show how politics are affecting public health

What does generative AI mean for health care? We asked experts

Pancreatic cancer is often deadly, but new discoveries are raising hope

Duchenne breakthrough therapy leaves behind pioneering families

Protect nursing home residents from future pandemics

How one medical school became remarkably diverse

The world needs the new pandemic treaty

Tori Bowie and the unacceptable rates of Black maternal death

Guardant Health colon cancer test endorsed by FDA advisory panel

leisure time

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Overprescribed: High cost isn't America's only drug problem

UnitedHealth, in a surprise, takes aim at Steward’s physician group

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

The Bio Revolution is changing business and society

Mass General Brigham physicians react to latest merger step

focus

entertainment

focus

Wikipedia